We are a late-stage development company focused on the development of
processes and products for the ex vivo production and sale of human cell
products for use in cell therapy and regenerative medicine. Our pre-clinical and
clinical product development programs utilize adult bone marrow stem and
progenitor cells for forming solid tissues such as bone, vascular tissue,
cartilage, and blood and immune system cells.

Cell therapy is the use of living cells in the treatment of medical
disorders. These cells can either be used in conjunction with, or as a
replacement for, traditional therapies. Cell therapy began with simple, but very
effective, blood and platelet transfusions, expanding later to include
specialized procedures including hematopoietic stem cell transplants obtained
from the marrow or from the blood stream after stem cell mobilization.  ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2004%2f09%2f13%2f0000950137-04-007675.html#FIS_BUSINESS"